CD274 and neoplasm: Interestingly, in contrast to the metastastic setting, a clinical benefit was seen independently of the expression of PD-L1 on tumor cells in the early setting of TNBC (Cortes et al. 2020; Mittendorf et al. 2020; Schmid et al. 2020a, b, c; Schmid et al. 2021).